Neuronetics Valuation
| STIM Stock | USD 0.84 0.04 5.00% |
Today, the firm appears to be undervalued. Neuronetics secures a last-minute Real Value of $2.6 per share. The latest price of the firm is $0.84. Our model forecasts the value of Neuronetics from analyzing the firm fundamentals such as Profit Margin of (0.45) %, current valuation of 51.61 M, and Return On Equity of -1.0 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Neuronetics' valuation include:
Price Book 2.5961 | Enterprise Value 51.6 M | Enterprise Value Ebitda (2.02) | Price Sales 0.3518 | Enterprise Value Revenue 0.7098 |
Undervalued
Today
Please note that Neuronetics' price fluctuation is dangerous at this time. Calculation of the real value of Neuronetics is based on 3 months time horizon. Increasing Neuronetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neuronetics stock is determined by what a typical buyer is willing to pay for full or partial control of Neuronetics. Since Neuronetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neuronetics Stock. However, Neuronetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.84 | Real 2.6 | Target 8.0 | Hype 0.83 | Naive 0.71 |
The intrinsic value of Neuronetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Neuronetics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Neuronetics helps investors to forecast how Neuronetics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neuronetics more accurately as focusing exclusively on Neuronetics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Neuronetics' intrinsic value based on its ongoing forecasts of Neuronetics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Neuronetics' closest peers.
Neuronetics Cash |
|
Neuronetics Valuation Trend
Knowing Neuronetics' actual value is paramount for traders when making sound investment determinations. Using both Neuronetics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Neuronetics Total Value Analysis
Neuronetics is at this time forecasted to have valuation of 51.61 M with market capitalization of 25.35 M, debt of 62.47 M, and cash on hands of 73.7 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Neuronetics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
51.61 M | 25.35 M | 62.47 M | 73.7 M |
Neuronetics Investor Information
About 53.0% of the company shares are owned by institutional investors. The book value of Neuronetics was at this time reported as 1.18. The company recorded a loss per share of 1.22. Neuronetics had not issued any dividends in recent years. Based on the key indicators related to Neuronetics' liquidity, profitability, solvency, and operating efficiency, Neuronetics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Neuronetics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neuronetics has an asset utilization ratio of 61.6 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that Neuronetics is more efficient with each dollar of assets it utilizes for everyday operations.Neuronetics Ownership Allocation
Neuronetics maintains a total of 30.35 Million outstanding shares. Over half of Neuronetics' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Neuronetics Profitability Analysis
The company reported the previous year's revenue of 71.35 M. Net Loss for the year was (30.19 M) with profit before overhead, payroll, taxes, and interest of 49.72 M.About Neuronetics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Neuronetics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Neuronetics based exclusively on its fundamental and basic technical indicators. By analyzing Neuronetics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Neuronetics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuronetics. We calculate exposure to Neuronetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neuronetics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 51.7 M | 45.2 M | |
| Pretax Profit Margin | (0.42) | (0.44) | |
| Operating Profit Margin | (0.43) | (0.45) | |
| Net Loss | (0.42) | (0.44) | |
| Gross Profit Margin | 0.72 | 0.85 |
Neuronetics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Neuronetics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 28.7 M |
Neuronetics Current Valuation Indicators
Neuronetics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Neuronetics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Neuronetics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Neuronetics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Neuronetics' worth.When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.